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ABSTRACT Entry into mitosis is initiated by synthesis of cyclins, which bind and activate cy-
clin-dependent kinase 1 (Cdk1). Cyclin synthesis is gradual, yet activation of Cdk1 occurs in a 
stepwise manner: a low level of Cdk1 activity is initially generated that triggers early mitotic 
events, which is followed by full activation of Cdk1. Little is known about how stepwise acti-
vation of Cdk1 is achieved. A key regulator of Cdk1 is the Wee1 kinase, which phosphorylates 
and inhibits Cdk1. Wee1 and Cdk1 show mutual regulation: Cdk1 phosphorylates Wee1, 
which activates Wee1 to inhibit Cdk1. Further phosphorylation events inactivate Wee1. We 
discovered that a specific form of protein phosphatase 2A (PP2ACdc55) opposes the initial 
phosphorylation of Wee1 by Cdk1. In vivo analysis, in vitro reconstitution, and mathematical 
modeling suggest that PP2ACdc55 sets a threshold that limits activation of Wee1, thereby al-
lowing a low constant level of Cdk1 activity to escape Wee1 inhibition in early mitosis. These 
results define a new role for PP2ACdc55 and reveal a systems-level mechanism by which dy-
namically opposed kinase and phosphatase activities can modulate signal strength.
INTRODUCTION
Mitosis is an intricate and precisely ordered series of events that re-
sults in chromosome segregation and cell division. The key molecular 
event that initiates mitosis is activation of cyclin-dependent kinase 1 
(Cdk1; Morgan, 2007). Cdk1 activation requires binding of mitotic 
cyclins, which are synthesized anew each cell cycle and accumulate 
gradually during entry into mitosis. In human somatic cells and Xeno-
pus eggs, activation of Cdk1 occurs in a stepwise manner: a low 
constant level of Cdk1 activity is initially generated in early mitosis, 
which is followed by full, switch-like activation of Cdk1 (Solomon 
et al., 1990; Pomerening et al., 2005; Lindqvist et al., 2007; Deibler 
and Kirschner, 2010). Thus a gradually increasing signal generated 
by cyclin synthesis is converted to stepwise activation of Cdk1. This 
also appears to be true in budding yeast, where a low threshold of 
Cdk1 activity is required for initiation of mitotic spindle assembly and 
a higher threshold initiates spindle elongation (Rahal and Amon, 
2008). Stepwise activation of Cdk1 helps ensure that mitotic events 
occur in the proper order (Deibler and Kirschner, 2010). More gener-
ally, the molecular mechanisms by which a gradually increasing sig-
nal is converted to a step function are of great interest.
The Wee1 kinase and the Cdc25 phosphatase play important 
roles in modulation of Cdk1 activity during entry into mitosis (Nurse, 
1975; Russell and Nurse, 1986, 1987). Wee1 phosphorylates Cdk1 
on a conserved tyrosine, thereby inhibiting Cdk1 and delaying entry 
into mitosis (Gould and Nurse, 1989). Cdc25 promotes entry into 
mitosis by removing the inhibitory phosphate (Gautier et al., 1991; 
Kumagai and Dunphy, 1991). Wee1 and Cdc25 are thought to con-
tribute to the abrupt, switch-like activation of Cdk1 via feedback 
loops in which Cdk1 inhibits Wee1 and activates Cdc25 (Izumi et al., 
1992; Kumagai and Dunphy, 1992; Hoffman et al., 1993; Izumi and 
Maller, 1993; Tang et al., 1993; Mueller et al., 1995). They also en-
force cell cycle checkpoints that delay entry into mitosis until previ-
ous events have been completed (Rupes, 2002; Kellogg, 2003; 
Karlsson-Rosenthal and Millar, 2006; Keaton and Lew, 2006).
Recent work established that Wee1 plays an important role in the 
mechanism that generates a low plateau of Cdk1 activity in early 
mitosis. In vertebrate cells, low-level activation of Cdk1 in early 
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mitosis occurs in the presence of active Wee1 and is dependent 
upon Wee1 (Deibler and Kirschner, 2010). These seemingly para-
doxical findings suggest that Wee1 does not act in a simple all-
or-nothing manner to inhibit Cdk1. Rather, it appears that the activ-
ity of Wee1 can be restrained to allow a low level of Cdk1 activity to 
be generated in early mitosis. A mechanism that restrains Wee1 also 
appears to operate in budding yeast because two key early mitotic 
events occur in the presence of active Wee1. First, a low level of 
Cdk1 activity in early mitosis initiates a positive feedback loop that 
promotes transcription of mitotic cyclins (Amon et al., 1993). Wee1 
is present in excess when mitotic cyclins first accumulate and is ca-
pable of inhibiting both nuclear and cytoplasmic pools of Cdk1 
(Sreenivasan and Kellogg, 1999; Harvey and Kellogg, 2003; Harvey 
et al., 2005; Keaton et al., 2008). Thus initiation of the positive feed-
back loop requires a mechanism by which Cdk1 can be activated in 
the presence of Wee1. Second, checkpoints that block nuclear divi-
sion via activation of Wee1 cause an arrest at the short-spindle stage 
of early mitosis (Carroll et al., 1998; Sreenivasan and Kellogg, 1999; 
Theesfeld et al., 1999). Since formation of a short spindle requires a 
low level of mitotic Cdk1 activity, this further suggests that low-level 
activation of Cdk1 occurs in the presence of active Wee1 (Fitch 
et al., 1992; Rahal and Amon, 2008).
How is a low level of Cdk1 activity generated in early mitosis in 
the presence of active Wee1? Also, how is a low constant level of 
Cdk1 activity maintained in early mitosis as cyclin levels rise? Inves-
tigations into the mechanisms that regulate Wee1 and Cdk1 during 
entry into mitosis have provided clues. In budding yeast, Cdk1 as-
sociated with the mitotic cyclin Clb2 directly phosphorylates Wee1, 
which stimulates Wee1 to bind, phosphorylate, and inhibit Cdk1 
(Harvey et al., 2005). Thus Cdk1 activates its own inhibitor. A similar 
mechanism acts in human cells, which suggests that it is conserved 
(Deibler and Kirschner, 2010). When Cdk1 activity is inhibited in 
vivo, Wee1 undergoes rapid, quantitative dephosphorylation, which 
reveals that phosphorylation of Wee1 by Cdk1 is opposed by a 
phosphatase (Harvey et al., 2005). After the initial phosphorylation 
and activation of Wee1 by Cdk1 in early mitosis, further phosphory-
lation events cause full hyperphosphorylation of Wee1 and dissocia-
tion of the Wee1-Cdk1/cyclin complex, which likely represents the 
inhibition of Wee1 that is necessary for full entry into mitosis (Harvey 
et al., 2005; Deibler and Kirschner, 2010).
We used these findings as a starting point to investigate how 
activation of Cdk1 is controlled during entry into mitosis. This led 
to the discovery that PP2ACdc55 opposes the initial phosphorylation 
and activation of Wee1 by Cdk1/Clb2 in early mitosis. In vitro re-
constitution and mathematical modeling indicate that PP2ACdc55 
sets a threshold that limits activation of Wee1 in early mitosis, 
thereby allowing a low level of Cdk1/Clb2 activity to escape Wee1 
inhibition and initiate early mitotic events. Quantitative analysis 
and mathematical modeling of Wee1 activation further suggest 
the existence of a systems-level mechanism that keeps the activity 
of Cdk1/Clb2 at a low constant level as cyclin levels rise during 
early mitosis.
RESULTS
Cdc28/Clb2 phosphorylates Swe1 on Cdc28 
consensus sites
We first carried out an analysis of the mechanism by which mitotic 
Cdk1/cyclin stimulates activation of Wee1. In budding yeast, Wee1 
is referred to as Swe1 and Cdk1 is referred to Cdc28. In previous 
work, we reconstituted phosphorylation of Swe1 by Cdc28/Clb2 in 
vitro and used mass spectrometry to map phosphorylation sites 
(Harvey et al., 2005). We found that Cdc28/Clb2 phosphorylated 
Swe1 on eight of 13 possible minimal Cdc28 (Cdk1) consensus sites 
(S/T-P), as well as on 10 nonconsensus sites. Most sites were also 
identified on Swe1 isolated from cells, suggesting that they are 
physiologically relevant. A swe1-18A mutant that lacked these sites 
eliminated Swe1 hyperphosphorylation in vivo and caused prema-
ture entry into mitosis. In addition, the mutant protein failed to form 
a complex with Cdc28/Clb2. These observations suggested a model 
in which initial phosphorylation of Swe1 by Cdc28/Clb2 leads to 
formation of a Swe1-Cdc28/Clb2 complex that drives inhibitory 
phosphorylation of Cdc28/Clb2.
A limitation of these phosphorylation site-mapping experiments 
is that they were unable to provide information on the stoichiometry 
of phosphorylation. Thus it was possible that they identified sites 
phosphorylated at stoichiometries too low to be significant. To de-
termine which of the 18 sites played a significant role in Swe1 activa-
tion by Cdc28/Clb2, we used a quantitative method called stable 
isotope labeling with amino acids in culture (SILAC; Ong et al., 
2002). This approach allows estimation of the stoichiometry of phos-
phorylation via use of heavy isotope–labeled, unphosphorylated 
reference peptides.
We again reconstituted phosphorylation of Swe1 by Cdc28/Clb2 
in vitro (Figure 1A). Unphosphorylated and phosphorylated Swe1 
were mixed with isotope-labeled unphosphorylated Swe1, and the 
accumulation of phosphorylated peptides and depletion of the cog-
nate unphosphorylated peptides were monitored. The relative 
abundance ratios of the unphosphorylated peptides upon phos-
phorylation were used to calculate site stoichiometry. We performed 
two independent analyses using peptides generated by digesting 
Swe1 with trypsin or lysC.
Standard site mapping identified many sites, including most of 
the sites identified in our previous analysis (Supplemental Table S1; 
Harvey et al., 2005). However, SILAC revealed that the only sites 
phosphorylated at a measurable stoichiometry were Cdc28 consen-
sus sites (Table 1). An exception was a phosphorylation that occurred 
within amino acids 159–162, which likely represents Swe1 autophos-
phorylation on a tyrosine. In two cases, peptides with multiple sites 
underwent quantitative phosphorylation; however, the SILAC analy-
sis indicates only that these peptides were phosphorylated at high 
stoichiometry on one or more sites. In these cases, we believe that 
it is likely that only the Cdc28 consensus sites were phosphorylated 
at high stoichiometry.
Phosphorylation of Cdc28 consensus sites is required 
for Swe1 activity in vivo
SILAC analysis demonstrated that the initial phosphorylation of 
Swe1 by Cdc28/Clb2 occurs primarily on Cdc28 consensus sites, 
which suggested that phosphorylation of consensus sites alone 
drives activation of Swe1 by Cdc28/Clb2. To test whether Cdc28 
consensus sites are required for Swe1 activity, we analyzed a mutant 
version of Swe1 that lacked eight of the Cdc28 consensus sites iden-
tified by mass spectrometry (swe1-8A, sites mutated: T45A, S111A, 
T121A, S133A, T196A, S201A, S263A, and T373A). We previously 
found that the swe1-8A mutant largely eliminated phosphorylation 
of Swe1 in vivo (Harvey et al., 2005). Moreover, previous work estab-
lished that loss of Swe1 causes premature entry into mitosis and re-
duced cell size (Jorgensen et al., 2002; Harvey and Kellogg, 2003; 
Harvey et al., 2005; Rahal and Amon, 2008). In this study, we found 
that swe1-8A caused premature entry into mitosis, as detected by 
assembly of short mitotic spindles (Figure 1B). The swe1-8A mutant 
also caused reduced cell size and a complete loss of Cdc28 inhibi-
tory phosphorylation (Figure 1, C–D). Finally, the swe1-8A protein 
failed to form a complex with Cdc28/Clb2 in crude extracts 
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(Figure 1E). The sites mutated in swe1-8A were located in the N-
terminus, far from the kinase domain, and mutation of these sites in 
the swe1-18A mutant did not affect the intrinsic kinase activity of 
Swe1 (Harvey et al., 2005). A swe1-13A mutant that lacked all 13 
minimal Cdc28 consensus sites also caused premature entry into 
mitosis and a reduced cell size (unpublished data).
We next tested whether the swe1-8A protein was phosphory-
lated by Cdc28/Clb2 in vitro. We utilized a mutant form of Cdc28 
that cannot be phosphorylated by Swe1 (cdc28-Y19F), which al-
lowed us to carry out reactions without the complication of Cdc28 
inhibition by Swe1. The swe1-8A protein was resistant to phospho-
rylation by purified cdc28-Y19F/Clb2 (Figure 1F). In contrast, a 
swe1-10ncs protein that lacked the nonconsensus sites identified in 
our original study was phosphorylated to the same extent as wild-
type Swe1, which supported the conclusion that initial phosphoryla-
tion of Swe1 by Cdc28/Clb2 occurs on Cdc28 consensus sites 
(Figure 1F).
These observations are consistent with a model in which Cdc28/
Clb2 activates Swe1 and drives formation of the Swe1-Cdc28/Clb2 
complex via phosphorylation of Cdc28 consensus sites. Note that 
only a quantitatively phosphorylated form of Swe1 forms a complex 
with Cdc28/Clb2 in wild-type cells (Figure 1E and Harvey et al., 
2005). Based on its electrophoretic mobility, 
this form is likely to correspond to the form 
of Swe1 that has been quantitatively phos-
phorylated by Cdc28/Clb2 on consensus 
sites, which suggests that Swe1 must be 
quantitatively phosphorylated to bind and 
inhibit Cdc28.
To further investigate the mechanism 
and function of consensus site phosphoryla-
tion, we created two additional phosphory-
lation site mutants in which a smaller num-
ber of sites were mutated. In the first mutant, 
we mutated two sites that correspond to 
optimal Cdc28 consensus sites (S/TPXXR/K; 
swe1-T196A,T373A). In the second mutant, 
we mutated two sites that correspond to the 
minimal Cdc28 consensus site (S/TP; swe1-
S133A,S263A). In both cases, we chose sites 
that were quantitatively phosphorylated by 
Cdc28/Clb2 in the mass spectrometry anal-
ysis. There are numerous other phosphory-
lation site mutants that would be interesting 
to analyze in this context; these mutants 
were selected to provide a preliminary anal-
ysis of the roles of different classes of sites 
and to test whether phosphorylation of all 
sites is necessary for full Swe1 activity. For 
both mutants, we analyzed cell size, Cdc28 
inhibitory phosphorylation, Swe1 phospho-
rylation, and formation of the Swe1-Cdc28/
Clb2 complex (Figure 2).
Mutation of the optimal Cdc28 consen-
sus sites (swe1-T196A,T373A) caused a 
small-size phenotype similar to a swe1Δ and 
a severe reduction in Cdc28 inhibitory phos-
phorylation, consistent with loss of Swe1 
function (Figure 2, A and B). Intermediate 
phosphorylation forms of the swe1-
T196A,T373A protein could be detected, 
but appeared to be reduced (Figure 2C, 
compare 50-min time points). The swe1-T196A,T373A protein com-
pletely failed to form a complex with Cdc28/Clb2 (Figure 2D).
Mutation of the minimal Cdc28 consensus sites (swe1-
S133A,S263A) caused reduced cell size (Figure 2A), as well as de-
layed Cdc28 inhibitory phosphorylation (Figure 2B; compare 50- to 
60-min time points in wild-type cells to the same time points in 
swe1-S133A,S263A cells). It also appeared to cause a reduction in 
Swe1 phosphorylation: most of the swe1-S133A,S263A protein was 
present in a rapidly migrating form at early time points (Figure 2C; 
compare 50- to 60-min time points). Phosphorylated forms of swe1-
S133A, S263A eventually appear, but only at later times, when 
Cdc28/Clb2 accumulates to higher levels. The swe1-S133A,S263A 
protein was capable of forming a complex with Cdc28/Clb2.
The behavior of the swe1-S133A,S263A and swe1-T196A,T373A 
mutants indicates that the consensus sites are not all equivalent in 
terms of function. A model that could explain the behavior of the 
mutants is that phosphorylation occurs in an ordered and coopera-
tive manner. In this model, phosphorylation of S133 or S263 
would occur first, promoting subsequent phosphorylation events. 
Phosphorylation of T196 and T373 would occur last, stimulating 
Swe1 activity by promoting formation of the Swe1-Cdc28/Clb2 
complex. This model further postulates that phosphorylation of 
FIGURE 1: Phosphorylation of Cdc28 consensus sites is necessary for Swe1 activity in vivo. 
(A) Purified Cdc28/Clb2 quantitatively phosphorylates purified Swe1 in vitro. Phosphorylation 
of Swe1 causes an electrophoretic mobility shift that is detected by Western blot analysis. 
(B) Wild-type and swe1-8A cells were released from a G1 arrest, and the percentage of cells with 
short mitotic spindles was determined at the indicated times and plotted as a function of time. 
Error bars represent SEM for three independent experiments. (C) Cell size distributions of 
log-phase cultures of wild-type, swe1Δ, and swe1-8A strains. Each trace is the average of 15 
independent cultures. (D) Cells of the indicated genotypes were released from a G1 arrest, and 
samples were taken at the indicated times. Cdc28 phosphotyrosine was monitored by Western 
blotting. (E) Wild-type and swe1-8A cells carrying GAL1-3×HA-CLB2 were grown to midlog 
phase, and expression of 3×HA-Clb2 was induced with 2% galactose for 3 h at 30°C. Extracts 
were made, and 3×HA-Clb2 was immunoprecipitated with an anti-HA antibody. As a control, 
identical precipitations were carried out using an anti-GST antibody. Coprecipitation of Swe1 
was assayed by Western blotting. The panels labeled “Extract” show Western blots of 3×HA-
Clb2 and Swe1 in the crude extracts used for the immunoprecipitations. (F) Purified 3×HA-Swe1, 
3×HA-swe1-8A, or 3×HA-swe1-10ncs were incubated with increasing amounts of purified 
cdc28-Y19F/Clb2-3×HA in the presence of ATP. Phosphorylation of Swe1 was detected as an 
electrophoretic mobility shift on a Western blot.
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entry into mitosis and Cdc28 inhibitory phosphorylation. Canoni-
cal PP2A is a heterotrimeric complex composed of a catalytic sub-
unit, a scaffolding subunit, and a regulatory subunit. Cells express 
multiple regulatory subunits that associate with PP2A in a mutually 
exclusive manner. In budding yeast, PP2A associates primarily with 
two regulatory subunits called Rts1 and Cdc55, forming distinct 
complexes called PP2ARts1 and PP2ACdc55, respectively. Inactivation 
of the catalytic subunit after cells have passed through G1 phase 
causes defects in entry into mitosis; cells arrest with low levels of 
mitotic cyclin mRNA and protein and reduced specific activity of 
mitotic Cdc28 (Lin and Arndt, 1995). Similarly, cdc55Δ causes in-
creased Cdc28 inhibitory phosphorylation, delayed accumulation 
of mitotic cyclin, and a prolonged delay in early mitosis (Minshull 
et al., 1996; Yang et al., 2000; Pal et al., 2008). These phenotypes 
are rescued by swe1Δ or cdc28-Y19F (Yang et al., 2000; Pal et al., 
2008). Conversely, PP2ACdc55 mutants are enhanced by inactivation 
of Mih1, the budding yeast homologue of Cdc25 (Lin and Arndt, 
1995; Pal et al., 2008). For example, mih1Δ causes lethality in 
cdc55Δ cells, which is rescued by swe1Δ. Together, these observa-
tions show that PP2ACdc55 promotes entry into mitosis via regula-
tion of Cdc28 inhibitory phosphorylation. Xenopus PP2A also con-
trols entry into mitosis, and is thought to regulate Wee1 and Cdc25 
(Félix et al., 1990; Kumagai and Dunphy, 1992; Tang et al., 1993; 
Izumi and Maller, 1995; Mueller et al., 1995; Castilho et al., 2009; 
Mochida et al., 2009).
To test whether PP2ACdc55 opposes phosphorylation of Swe1, 
we assayed Swe1 hyperphosphorylation in synchronized cdc55Δ 
cdc28-Y19F cells. The cdc28-Y19F allele eliminated the mitotic 
delay caused by cdc55Δ, which allowed cell cycle synchroniza-
tion. We found that Swe1 prematurely shifted to a partially 
phosphorylated form in cdc55Δ cdc28-Y19F cells (Figure 3A). 
 
Site
 
Local sequence
Fractional occupancy (%)
LysC Trypsin
T45 IGGSTPTNK 86 88
S111, T121b IKRWSPFHENESVTTPITK 95 94
S133 EKTNSPISL 97 97
[159–162] TSSS[SSYS]VAK 55 62
T196 RIPETPVKK 98 99
S201 PVKKSPLVE 49 ND
S263 TIDSSPLSE 97 97
T280, S284, [286–297]b HNNQTNILSP[TNSLVTNSSPQT]LHSN 96 97
T373 EEISTPTRR 96 ND
S418 TDSSSPLNSK ND 94
aFor peptides with multiple phosphorylation sites, the fractional occupancy indicates the fraction of peptides phosphorylated on one or more sites; the fractional 
occupancy of individual sites could not be determined. Swe1 was purified from yeast grown in the presence of 13C stably, isotopically labeled lysine (“heavy”) or 
natural lysine (“light”) and phosphatase treated. Light Swe1 was incubated in a mock reaction without added kinase or with Cdk1/Clb2. The light Swe1 from each 
reaction was then mixed with heavy Swe1 that had been treated with phosphatase, and the mixtures were resolved by SDS–PAGE. Coomassie Blue–stained bands 
were excised, proteolysed, and examined by liquid chromatography–mass spectrometry/mass spectrometry on an LTQ-Orbitrap mass spectrometer (Thermo-Fisher 
Scientific, San Jose, CA), and matched to peptide sequences using SEQUEST software (Thermo-Fisher Scientific). Abundance ratios of unphosphorylated peptides 
(heavy:light [H:L]) were automatically calculated using Vista (Bakalarski et al., 2008). As peptides became phosphorylated, the pool of light unphosphorylated 
peptides was depleted and the H:L ratio increased. Using ratios for peptides that lack serine, threonine, and tyrosine as a baseline, we calculated the phospho-
rylated fraction for each peptide as FPhos = 1 − FUn/FPep, where FPhos = fraction phosphorylated, FUn = average H:L ratio of unphosphorylatable peptides in each 
experiment, and FPep = average H:L ratio of each unphosphorylated peptide. Phosphorylation sites for each peptide were inferred from the appearance of peptides 
bearing these sites in the light fraction upon phosphorylation with Cdk1/Clb2. Confidently localized sites are shown bold and underlined. Where we were unable to 
determine precise site localization, brackets indicate the range of possible assignments. LysC-digested and trypsin-digested samples represent distinct biological 
replicates of the experiments. ND, not determined.
bThe stoichiometry of these sites could not be assessed independently. Reported data indicate the fraction of peptides phosphorylated on one or more sites.
TABLE 1: Estimated fractional phosphorylation occupancy of key sites in Swe1.a
T196 and T373 eventually occurs in the swe1-S133A,S263A mutant, 
but inefficiently, and therefore only after Cdc28/Clb2 activity has 
risen to higher levels. Thus activation of Swe1 would be delayed in 
the swe1-S133A,S263A mutant, which would explain the observed 
premature accumulation of active Cdc28 and reduced cell size. This 
model is consistent with the observation that only the quantita-
tively phosphorylated form of wild-type Swe1 binds to Cdc28/Clb2 
(Figure 1E; Harvey et al., 2005).
Previous work on the fibroblast growth factor receptor found that 
it undergoes multi-site phosphorylation in a sequential and precisely 
ordered manner, which provides a precedent for a sequential mech-
anism of Swe1 phosphorylation (Furdui et al., 2006). However, ex-
tensive additional experiments will be required to clearly define the 
mechanism of multi-site phosphorylation of Swe1. Although the be-
havior of the Swe1 phosphorylation site mutants suggests the pres-
ence of cooperativity, these observations must be interpreted with 
caution because phosphorylation has an unpredictable effect on 
gel mobility: multiple phosphorylations may show no gel shift, while 
a single phosphorylation may show a large one. Thus it is not pos-
sible to know definitively which sites or how many sites have been 
phosphorylated based on the electrophoretic mobility of a protein. 
Quantitative mass spectrometry will be necessary to fully character-
ize the effects of the mutations on Swe1 phosphorylation.
PP2ACdc55 opposes phosphorylation of Swe1 by Cdc28 
in vivo
We next used a candidate approach to search for the phosphatase 
that opposes phosphorylation of Swe1 by Cdc28. We reasoned 
that inactivation of the phosphatase should cause premature phos-
phorylation of Swe1. PP2ACdc55 was a strong candidate because 
evidence from diverse systems has indicated it is a key regulator of 
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Moreover, there was a loss of hypophosphorylated forms of 
Swe1 in cdc55Δ cdc28-Y19F cells (Figure 3A). The cdc28-Y19F 
mutant alone did not cause premature hyperphosphorylation of 
Swe1 (Figure 3A). In cdc55Δ cells, Swe1 was present at all time 
points due to poor cell cycle synchrony, and was constitutively in 
the partially phosphorylated form (Supplemental Figure S1A). 
Swe1 did not undergo premature hyperphosphorylation in rts1Δ 
cells, which indicated that PP2ARts1 does not play a role in op-
posing the initial phosphorylation of Swe1 (Figure S1B). Swe1 
failed to undergo full hyperphosphorylation in rts1Δ cells, which 
suggested that PP2ARts1 plays a role in events required for full 
hyperphosphorylation of Swe1.
To further investigate the role of PP2ACdc55, we tested whether 
PP2ACdc55 was required for dephosphorylation of Swe1 in vivo af-
ter inhibition of an analogue-sensitive allele of Cdc28 (cdc28-
as1). We were unable to recover a cdc28-as1 cdc55Δ double mu-
tant, but we were able to recover the double mutant in the 
presence of a kinase-dead allele of SWE1 (swe1-kd) We synchro-
nized cdc28-as1 swe1-kd and cdc28-as1 swe1-kd cdc55Δ cells 
and inhibited cdc28-as1 as cells were entering mitosis. Inhibition 
of cdc28-as1 in the control cells caused rapid and nearly com-
plete loss of swe1-kd phosphorylation (Figure 3B). Inhibition of 
cdc28-as1 in cdc55Δ cells caused a partial dephosphorylation of 
swe1-kd. The partial dephosphorylation of swe1-kd could be due 
to another phosphatase that makes a minor contribution, or to 
the nonspecific activity of multiple phosphatases. We further 
found that overexpression of Cdc55 from the GAL1 promoter 
caused delayed phosphorylation of Swe1 (Figure 3C, compare 
60- to 70-min time points in each strain). These data, combined 
with the fact that cdc55Δ causes nearly quantitative hyperphos-
phorylation of Swe1 in vivo, indicate that PP2ACdc55 is the primary 
phosphatase that acts on Swe1 during 
early mitosis.
The swe1-8A mutant failed to undergo 
premature hyperphosphorylation in cdc55Δ 
cells, which demonstrated that PP2ACdc55 
opposes phosphorylation of the Cdc28 
consensus sites (Figure 3D). Moreover, 
swe1-8A rescued the elongated cell mor-
phology caused by cdc55Δ, providing fur-
ther evidence that PP2ACdc55 targets the 
consensus sites (Figure 3E; 62% of cdc55Δ 
cells were elongated, whereas no elon-
gated cells were detected in cdc55Δ swe-
-8A cells). Full hyperphosphorylation of 
Swe1 was delayed in cdc55Δ cdc28-Y19F 
cells, which indicated that PP2ACdc55 con-
trols additional events required for full hy-
perphosphorylation of Swe1 later in mitosis 
(Figure 3A).
PP2ACdc55 can effectively oppose 
phosphorylation of Swe1 by Cdc28/
Clb2 in vitro
To determine whether PP2ACdc55 is likely 
to act directly on Swe1, we used in vitro 
reconstitution to test whether PP2ACdc55 
can effectively oppose phosphorylation 
of Swe1 by Cdc28/Clb2. We used immuno-
affinity chromatography with specific pep-
tide elution to purify triple hemagglutinin-
Swe1 (3×HA-Swe1), cdc28-Y19F/Clb2-3×HA, 
and PP2ACdc55-3×HA. Purifications were carried out in the presence 
of 1 M KCl to remove peripherally associated proteins. Examples 
of the purified proteins are shown in Figure S2. We used the 
cdc28-Y19F mutant to create a simplified system in which Swe1 
cannot phosphorylate and inhibit Cdc28, which allowed us to 
focus on phosphorylation of Swe1.
To ensure that reactions recapitulated conditions during early 
mitosis, we used Western blotting to assess relative levels of Clb2 
and Swe1 during the cell cycle. Clb2 and Swe1 were tagged with 
3×HA at their endogenous loci in the same strain, and levels of 
both proteins were assessed simultaneously in synchronized cells 
(Figure 3F). This revealed that Swe1 is present in excess during 
early mitosis, when Clb2 is first accumulating, and that Clb2 levels 
eventually exceed Swe1 levels. Note that the partially hyperphos-
phorylated form of Swe1 appears at low Clb2 levels in early mito-
sis, and that full hyperphosphorylation of Swe1 only occurs when 
Clb2 levels exceed Swe1 levels. Samples were electrophoresed for 
a short time to keep both proteins on the gel, so the resolution of 
Swe1 isoforms was reduced compared with Figure 3A. A similar 
approach revealed that Cdc55 is present in excess of both Swe1 
and Clb2 (unpublished data).
Reactions were initiated that contained Swe1, cdc28-Y19F/
Clb2, and increasing amounts of PP2ACdc55. The reactions were 
allowed to proceed for 20 min and an anti-HA antibody was 
used to detect phosphorylated forms of Swe1 by shifts in elec-
trophoretic mobility (Figure 3G). The antibody also detected 
Clb2-3×HA and Cdc55-3×HA, which allowed assessment of the 
relative amounts of each protein. Clb2-3×HA levels were just be-
low detection, and Swe1 was present in excess of Clb2, as in 
early mitosis. In the absence of PP2ACdc55, Swe1 was quantita-
tively phosphorylated by cdc28-Y19F/Clb2. Added PP2ACdc55 
FIGURE 2: Analysis of Swe1 phosphorylation site mutants. (A) Cell size distributions of 
log-phase cultures of wild-type, swe1Δ, swe1-T196A,T373A, and swe1-S133A,S263A. Each trace 
is the average of 15 independent cultures. The wild-type and swe1Δ traces plotted in Figure 1C 
and panel A are identical. (B and C) Cells of the indicated genotypes were released from a G1 
arrest into 30°C YPDA medium and samples were taken at the indicated times. The behavior of 
(B) Cdc28 phosphotyrosine and (C) Swe1 was assayed by Western blotting. (D) Wild-type, 
swe1-S133A,S263A, and swe1-T196A,T373A cells carrying GAL1-3×HA-CLB2 were grown to 
midlog phase and expression of 3×HA-Clb2 was induced with 2% galactose for 3 h at 30°C. 
Extracts were made and 3×HA-Clb2 was immunoprecipitated with an anti-HA antibody. As a 
control, identical precipitations were carried out using an anti-GST antibody. Coprecipitation of 
Swe1 was assayed by Western blotting.
3600 | S. L. Harvey et al. Molecular Biology of the Cell
effectively opposed phosphorylation of Swe1. Note that under 
these conditions, with very low concentrations of cdc28-Y19F/
Clb2 and excess Swe1, the extensive, full hyperphosphorylation 
of Swe1 by cdc28-Y19F/Clb2 we previously reported was not 
observed (Harvey et al., 2005). PP2ARts1 purified under identical 
conditions failed to oppose phosphorylation of Swe1 by Cdc28/
Clb2, which suggests Cdc55 confers specific functions upon 
PP2A (Figure 3G).
Inactivation of PP2ACdc55 causes a 
Swe1-dependent delay in accumulation 
of mitotic cyclin
We carried out in vivo experiments to fur-
ther analyze the role of PP2ACdc55 in entry 
into mitosis. Previous work found that 
cdc55Δ caused a large increase in Cdc28 
inhibitory phosphorylation and delayed 
accumulation of Clb2 (Minshull et al., 
1996; Yang et al., 2000; Pal et al., 2008). 
However, these studies were carried out 
using cdc55Δ cells. In contrast to the 
cdc55Δ cdc28-Y19F cells used for the ex-
periments in Figure 3, cdc55Δ cells have 
significant cell cycle defects and rapidly 
accumulate suppressors, which makes it 
difficult to clearly define the immediate 
effects of Cdc55 inactivation. We there-
fore generated a temperature-sensitive 
allele of CDC55 (cdc55-4), which allowed 
us to determine the immediate effects of 
inactivating Cdc55. DNA sequencing 
identified a single point mutation (C875T) 
in the cdc55-4 sequence compared with 
the wild-type CDC55 sequence, which 
results in conversion of threonine 292 
to methionine. Wild-type, cdc55-4, and 
cdc55-4 swe1Δ cells were released from a 
G1 arrest at the restrictive temperature, 
and formation of mitotic spindles was as-
sayed, as were levels of Clb2 protein 
(Figure 4, A and B). The cdc55-4 mutant 
caused a prolonged delay in accumula-
tion of Clb2 and formation of short mitotic 
spindles. The delay was eliminated by 
swe1Δ, which indicated the delay was due 
to a failure to properly regulate Cdc28 in-
hibitory phosphorylation. The cdc55-4 
mutant caused a 10-min delay in bud 
emergence, but this could not account for 
the 30-min delay in formation of short mi-
totic spindles (Figure S3).
The cdc55-4 mutant also caused a delay 
in formation of long mitotic spindles that 
was much greater than the delay in forma-
tion of short spindles. The delay was largely 
eliminated by swe1Δ, which demonstrated 
that PP2ACdc55-dependent regulation of 
Cdc28 inhibitory phosphorylation also plays 
a role in events required for the normal tim-
ing of spindle elongation.
A potential explanation for the delay in 
early mitotic events is that inactivation of 
Cdc55 causes defects in morphogenesis 
that activate a Swe1-dependent checkpoint. However, previous 
work suggested that activation of the morphogenesis checkpoint 
does not cause a significant delay in accumulation of Clb2 (Carroll 
et al., 1998). To further test this, we used a conditional septin mutant 
(cdc12-6) to activate the morphogenesis checkpoint. We detected a 
slight delay in accumulation of Clb2 protein in cdc12-6 mutants; 
however, the delay was not comparable to the prolonged delay 
caused by cdc55-4 (Figure 4C).
FIGURE 3: PP2ACdc55 opposes the initial phosphorylation of Swe1 by Cdc28. (A) Cells of the 
indicated genotypes were released from G1 arrest, and the behavior of Swe1 was assayed by 
Western blotting. The strains used for this experiment were generated in the A364A 
background. Similar results were obtained in the W303-1A strain background. (B) 1NM-PP1 was 
added to cdc28-as1 swe1-kd or cdc28-as1 swe1-kd cdc55Δ cells 65 min after release from G1 
arrest. Swe1 phosphorylation was assayed by Western blotting. (C) Cells were grown overnight 
in YEP medium containing 2% raffinose, and then arrested with α-factor at room temperature. 
After a 2-h incubation in the presence of α-factor, 2% galactose was added to initiate expression 
of GAL1-CDC55, and the incubation was continued for an additional 1 h. Cells were released 
from the arrest into galactose-containing YEP medium, and the behavior of Swe1 was assayed 
by Western blotting. (D) Cells of the indicated genotypes were released from G1 arrest into 
30°C YPD medium, and the behavior of Swe1 was assayed by Western blotting. (E) Cells of the 
indicated genotypes were grown overnight to log phase at room temperature in YPD medium 
and imaged by differential interference contrast microscopy. Scale bar: 5 μm. (F) Cells carrying 
Clb2-3×HA and Swe1-3×HA were released from a G1 arrest into 30°C YPD medium, and the 
behavior of Clb2 and Swe1 was monitored on the same Western blot. (G) The indicated 
combinations of purified protein complexes were incubated in the presence of ATP and purified 
dephosphorylated Swe1 for 20 min, and then analyzed by Western blotting. All of the 3×HA-
tagged proteins were detected on the same blot with an anti-HA antibody. Three different 
concentrations of PP2ACdc55 or PP2ARts1 that varied over a twofold range (indicated as 1×, 1.5×, 
and 2×) were added to the reactions.
Volume 22 October 1, 2011 PP2A-dependent modulation of Cdk1 activity | 3601 
A threshold model for the role of PP2ACdc55 in regulation 
of Swe1 and Cdc28
In previous work, it was hypothesized that inactivation of PP2A 
catalytic subunits causes reduced specific activity of Cdc28/
Clb2, thereby disrupting a positive feedback loop in which 
Cdc28/Clb2 promotes Clb2 transcription (Amon et al., 1993; Lin 
and Arndt, 1995). Our results provide strong support for this hy-
pothesis: inactivation of Cdc55 caused a prolonged delay in ac-
cumulation of Clb2. Moreover, Clb2 levels rose abruptly in wild-
type cells but more gradually in cdc55-4 cells, consistent with a 
failure in the positive feedback loop (Figure 4A). Our analysis of 
Swe1 regulation suggests an explanation for these observations. 
We found that Cdc28/Clb2 phosphorylates and activates Swe1, 
and that activation of Swe1 is opposed by PP2ACdc55. Thus inacti-
vation of PP2ACdc55 would be expected to result in hyperactive 
Swe1, which would phosphorylate and inhibit Cdc28/Clb2, lead-
ing to reduced specific activity of Cdc28/Clb2 and a failure in 
the positive feedback loop. In this model, PP2ACdc55 creates a 
threshold that limits activation of Swe1 by Cdc28/Clb2, thereby 
allowing a low level of Cdc28/Clb2 activity to accumulate in early 
mitosis. The low level of Cdc28/Clb2 activity triggers the positive 
feedback loop that promotes Clb2 transcription without trigger-
ing full entry into mitosis. When Cdc28/Clb2 activity rises above 
the threshold, Swe1 would be activated to bring Cdc28/Clb2 ac-
tivity back below the threshold, thus maintaining a low level of 
Cdc28/Clb2 activity in early mitosis. Swe1 is present in excess 
when mitotic cyclins first accumulate and is capable of inhibiting 
both nuclear and cytoplasmic pools of Cdc28 (Keaton et al., 
2008). Thus a mechanism for restraining Swe1 is necessary for 
initiation of the positive feedback loop. Cdc55 is localized to the 
nucleus and the cytoplasm, so it is present where activation of 
Swe1 must be restrained (Gentry and Hallberg, 2002).
Swe1 is hyperactive in cells that lack PP2ACdc55
We used a combination of in vivo analysis, quantitative analysis, 
and mathematical modeling to test the threshold model for 
PP2ACdc55 function. If PP2ACdc55 creates a threshold that limits 
activation of Swe1 by Cdc28/Clb2, one would predict that Swe1 
is hyperactive in cells that lack PP2ACdc55. We tested this by de-
termining whether cdc55Δ cells are sensitive to increased levels 
of Swe1. To do this, we induced overexpression of Swe1 from 
the MET25 promoter in wild-type and cdc55Δ cells. Expression 
of Swe1 in wild-type cells did not affect the rate of colony forma-
tion. In contrast, expression of Swe1 in cdc55Δ cells caused le-
thality, consistent with the idea that Swe1 is hyperactive in the 
absence of PP2ACdc55, which leads to mitotic arrest (Figure 4D).
The phosphorylation state of Swe1 represents a steady state
We next carried out further analysis of the reconstituted system. 
The threshold model suggests that phosphorylation of Swe1 will 
approach a steady state determined by the relative activities of 
Cdc28/Clb2 and PP2ACdc55. In vivo analysis is consistent with this: 
acute inhibition of Cdc28 causes rapid dephosphorylation of Swe1, 
and inactivation of PP2ACdc55 causes hyperphosphorylation of 
Swe1 (Figure 3 and Harvey et al., 2005). To determine whether the 
reconstituted system recapitulates steady-state regulation of Swe1, 
we set up reactions containing Swe1, PP2ACdc55, and two different 
concentrations of cdc28-Y19F/Clb2. The reactions were initiated 
by addition of ATP, and samples were taken at intervals to deter-
mine the time required to approach steady state (Figure 5A). Swe1 
phosphorylation approached steady state within 10–15 min in the 
presence of both low and high levels of cdc28-Y19F/Clb2. This is a 
biologically relevant timescale, because Clb2 accumulation in vivo 
occurs over a period of 40 min at the temperature used to carry 
out these reactions.
To further establish that the reactions were in dynamic opposi-
tion, a reaction was allowed to proceed for 15 min and okadaic acid 
was then added to inhibit PP2ACdc55. This caused rapid hyperphos-
phorylation of Swe1, which confirmed that phosphorylation and de-
phosphorylation were occurring in dynamic opposition (Figure 5B).
Quantitative analysis reveals an ultrasensitive response 
of Swe1 to rising levels of Cdc28/Clb2
Diverse experimental observations support the threshold model. 
However, a system that includes opposing kinase and phosphatase 
FIGURE 4: Inactivation of PP2ACdc55 causes a Swe1-dependent delay 
in Clb2 accumulation. (A and B) Cells of the indicated genotypes were 
released from G1 arrest into 35°C YPD medium. Samples were taken 
every 10 min at the indicated times. (A) Clb2 protein levels were 
monitored by Western blotting. (B) The percentage of cells with short 
or long spindles was determined and plotted as a function of time. 
Error bars represent SEM for three independent experiments. 
(C) Cells of the indicated genotypes were grown overnight to log 
phase, and then arrested with α-factor for 4 h at 20°C. Cells were 
released from the G1 arrest into 37°C YPD medium. Samples were 
taken every 10 min at the indicated times, and Clb2 protein levels 
were monitored by Western blotting. (D) Fivefold serial dilutions of 
cells of the indicated genotypes were grown on minimal media plates 
containing 2% dextrose in the presence or absence of 20 μg/ml 
l-methionine at 30°C. The MET25 promoter is induced in the absence 
of l-methionine.
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activities and multi-site phosphorylation 
can exhibit complex behaviors, and multi-
ple distinct behaviors are possible. To de-
termine which of the possible behaviors is 
exhibited by the system, one must use 
quantitative analysis and fitting of experi-
mental data to mathematical models. We 
therefore analyzed the reconstituted sys-
tem, as well as the individual phosphoryla-
tion and dephosphorylation reactions, with 
the goal of determining whether the system 
was capable of generating the behavior 
postulated by the model.
We first analyzed phosphorylation of 
Swe1 in steady-state reactions containing 
Swe1, PP2ACdc55, and increasing amounts of 
cdc28-Y19F/Clb2. We used fluorescent 
dye–based Western blotting with an anti-
HA antibody to detect phosphoforms of 
Swe1, as well as the HA-tagged Cdc55 and 
Clb2 added to the reactions (Figure 5C). 
The amounts of added Cdc28/Clb2 were 
set to be very low, and Swe1 levels were set 
to be in excess, to mimic the conditions dur-
ing early mitosis. Comparison of the Clb2 
signal in the in vitro reactions with the Clb2 
signal in crude extracts indicated the amount 
of cdc28-Y19F/Clb2 added to the reactions 
was significantly lower than the peak level of 
Cdc28/Clb2 reached in vivo.
Four forms of Swe1 could be detected in 
the presence of increasing amounts of 
cdc28-Y19F/Clb2. These are labeled in 
Figure 5C as bands 1–4. Based on its elec-
trophoretic mobility, band 4 corresponds to 
the form of Swe1 that is quantitatively phos-
phorylated on Cdc28 consensus sites. Be-
cause phosphorylation has an unpredictable 
effect on gel mobility, each of the lower 
bands may correspond to multiple forms of 
phosphorylated Swe1. However, the bands 
showed decreased electrophoretic mobility 
with increasing Cdc28/Clb2, indicating that 
they corresponded to increasingly phospho-
rylated forms of Swe1.
All four forms of Swe1 were quantitated 
in samples run in triplicate and plotted as a 
function of increasing amounts of cdc28-
Y19F/Clb2 (Figure 5D, circles show data 
from three experimental replicates). Analysis 
of the data for three independent experi-
ments utilizing different preparations of 
cdc28-Y19F/Clb2 and PP2ACdc55 revealed 
that formation of the most phosphorylated 
FIGURE 5: The response of Swe1 to rising levels of cdc28-Y19F/Clb2 is ultrasensitive. 
(A) Reactions containing Swe1, PP2ACdc55, and two concentrations of cdc28-Y19F/Clb2 were 
initiated by addition of ATP. Samples were taken at the indicated times, and the phosphorylation 
state of Swe1 was assayed by Western blotting. The amounts of cdc28-Y19F/Clb2 were chosen 
to demonstrate that the reactions carried out in (C) approach steady state within the reaction 
time at both low and high concentrations of cdc28-Y19F/Clb2 (a.u., arbitrary units). (B) Reactions 
containing Swe1 and cdc28-Y19F/Clb2 were incubated for 15 min in the presence or absence of 
ATP and PP2ACdc55 (lanes 1–3). Samples were taken from each reaction, and okadaic acid was 
then added to the reaction in lane 3, which was incubated for an additional 10 min before taking 
a sample (lane 4). Swe1 phosphorylation was assayed by Western blotting. (C) Phosphorylation 
of Swe1 (bands labeled 1–4) as a function of cdc28-Y19F/Clb2 concentration in the presence of 
a constant amount of PP2ACdc55. Reactions were allowed to proceed for 20 min. Alexa Fluor 
647–labeled phosphorylase B was used as a loading control. Proteins were assayed by 
quantitative Western blotting using a monoclonal HA antibody to detect each 3×HA-tagged 
protein. (D) Quantitation of the amount of each Swe1 band generated in the reactions shown in 
(C). Reactions were analyzed in triplicate; circles represent data from each of the three 
replicates. Each graph also shows a line that represents the solution of the pipeline model 
described in the Supplemental Information. (E) Swe1 shows an ultrasensitive response to rising 
levels of cdc28-Y19F/Clb2. We repeated the analysis using three independent preparations of 
purified cdc28-Y19F/Clb2 and two independent preparations of PP2ACdc55 to create three 
biological replicates of the steady-state analysis, and each biological replicate was measured in 
triplicate. The graphs show the average quantitation of the amount of Swe1 band 4 generated 
as a function of cdc28-Y19F/Clb2 
concentration for each biological replicate. 
Error bars represent SD. In each graph, a Hill 
function was fit through least-squares 
approximation, and the Hill coefficients (nH) 
are displayed.
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form of Swe1 (band 4) at steady state was nonlinear with respect to 
increasing amounts of cdc28-Y19F/Clb2. This kind of nonlinearity is 
also referred to as ultrasensitivity, which can be quantified by fitting 
the data to a Hill function. The corresponding Hill coefficient pro-
vides a quantitative measure of the ultrasensitivity. The Hill coeffi-
cient is sensitive to noise in the data, so we repeated the analysis 
using three independent preparations of purified cdc28-Y19F/Clb2 
and two independent preparations of PP2ACdc55 and found the aver-
age Hill coefficient to be 2.56 ± 0.43, which indicates an ultrasensi-
tive response (Figure 5E; each panel shows the results of an inde-
pendent experiment).
We also carried out experiments to analyze phosphorylation of 
Swe1 as a function of increasing cdc28-Y19F/Clb2 in the absence of 
PP2ACdc55. Reactions without PP2ACdc55 will go to completion (i.e., 
complete phosphorylation of Swe1), and therefore do not represent 
a steady-state system. Thus we stopped the reactions after an arbi-
trary time to capture Swe1 in a range of intermediate phosphoryla-
tion states. We carried out three independent repetitions of the ex-
periment, using the same protein preparations used for the 
experiments in Figure 5E, and measured Hill coefficients of 1.9, 2.0, 
and 2.3 (Figure S4). The fact that these reactions produced a Hill 
coefficient of greater than 1 suggests that there may be ultrasensi-
tivity that is intrinsic to phosphorylation of Swe1 by Cdc28. How-
ever, these results must be treated with caution for several reasons. 
First, if one repeated the experiment and stopped the reactions af-
ter different amounts of time, the Swe1 dose–response would look 
different. Therefore the ultrasensitivity of the dose–response in the 
absence of PP2ACdc55 is transient and can vary over time. In particu-
lar, as time increases sufficiently for the phosphorylation reaction to 
go to completion, the dose–response becomes constant, and the 
Hill coefficient loses its practical meaning. Since the ultrasensitivity 
observed in the absence of PP2ACdc55 is transient, it is a different 
type of phenomenon and cannot be compared with that observed 
for steady-state dose–responses in the presence of PP2ACdc55. A re-
lated consideration is that PP2ACdc55 may enforce a different order 
of phosphorylation if it dephosphorylates different sites on Swe1 
with different efficiencies. In this case, phosphorylation of Swe1 in 
the presence or absence of PP2ACdc55 would represent fundamen-
tally different reactions.
The ultrasensitive response of Swe1 to rising levels 
of Cdc28/Clb2 may be due to multi-step effects
Multiple mechanisms can generate ultrasensitivity, including zero-
order effects, substrate competition, and multi-step effects 
(Goldbeter and Koshland, 1981; Gunawardena, 2005; Kim and 
Ferrell, 2007). Multi-step effects can arise when a kinase or phos-
phatase acts distributively to modify multiple sites. An enzyme that 
acts distributively requires more “steps” to complete the task, 
which leads to multi-step effects that can give rise to limited ultra-
sensitivity (Gunawardena, 2005). Note that distributivity says noth-
ing about the order in which an enzyme modifies sites; a distributive 
enzyme may modify sites in a specific order or in a random order.
The presence of four Swe1 bands in steady-state reactions indi-
cated that at least four distinct phosphoforms of Swe1 were gener-
ated by largely distributive phosphorylation, since a completely pro-
cessive mechanism would generate only two bands (i.e., 
unphosphorylated and fully phosphorylated Swe1). This suggested 
that the observed ultrasensitivity may arise predominantly from 
multi-step effects. To test this, we modeled the system as a phos-
phorylation pipeline with four stages corresponding to the four 
bands in the gel, and assumed purely linear rates for phosphoryla-
tion and dephosphorylation (details provided in the Supplemental 
Information). To constrain the data further, we combined the steady-
state data in Figure 5, C and D, with data obtained by assaying the 
rate of phosphorylation of Swe1 by cdc28-Y19F/Clb2 in the absence 
of PP2ACdc55, and the rate of dephosphorylation of phosphorylated 
Swe1 by PP2ACdc55 in the absence of cdc28-Y19F/Clb2 activity, using 
the same preparations of cdc28-Y19F/Clb2 and PP2ACdc55 that were 
used for the steady-state reactions shown in Figure 5, C and D 
(Figure S5, A and B, circles represent data from three replicates). We 
found linear rate constants that provided an excellent fit to the 
steady-state data (represented by lines in the graphs in Figure 5D). 
Since we did not assume any nonlinearity in the model, which could 
give rise to zero-order effects or other forms of amplification, this 
suggests that the observed ultrasensitivity could be accounted for 
entirely by multi-step effects. The data for the individual phosphory-
lation and dephosphorylation reactions were also fitted (Figure S5, A 
and B, lines represent the behavior predicted by the model). These 
data were also reasonably well reproduced by the model, although 
there was a slight systematic error in at least one of the graphs, which 
points to the limitations of describing this enzymatic system with a 
simple linear-rate model involving only six variables. We conclude 
nevertheless that the model is a surprisingly accurate qualitative and 
quantitative representation of Swe1 phosphorylation. The linear 
pipeline model therefore provides a simple abstraction that largely 
accounts for the data, as well as a useful framework for carrying out 
further experiments to investigate the mechanisms underlying Swe1 
phosphorylation. We emphasize that the model is not intended to 
provide a final or conclusive description of the mechanism of Swe1 
phosphorylation. Moreover, our analysis thus far does not rule out 
the possibility that additional factors, such as cooperative phospho-
rylation of Swe1, contribute to the observed ultrasensitivity.
Interestingly, the model predicts that the threshold value (EC50) 
of Cdc28/Clb2 increases proportionally as the concentration of 
PP2ACdc55 is increased (Figure S6 and Supplemental Information). 
With higher concentrations of PP2ACdc55, a higher level of active 
Cdc28/Clb2 is needed to counter it, which suggests that PP2ACdc55 
can tune the level of Swe1 activation by Cdc28/Clb2.
Ultrasensitive activation of Swe1 allows generation 
of a stable low level of Cdc28 activity in early mitosis
How does ultrasensitivity contribute to the mechanisms that reg-
ulate Swe1 and Cdc28? In principle, the system could have 
evolved to generate a more simple linear response of Swe1 to 
increasing Cdc28/Clb2 activity. Thus it seemed likely that the ul-
trasensitivity plays an important role in control of early mitotic 
events. We therefore used modeling to test how ultrasensitivity 
could affect the behavior of the system in its biological context. 
To do this, we followed a strategy widely adopted in engineering 
of “opening the loop” and considering separately the steady-
state response of Cdc28/Clb2 to Swe1 and the steady-state re-
sponse of Swe1 to Cdc28/Clb2 (details provided in the Supple-
mental Information). We then put the separate responses back 
together, thereby closing the loop, and in this way determined 
the system behavior.
This analysis suggested that an ultrasensitive response of Swe1 
to Cdc28/Clb2 helps generate a stable level of active Cdc28/Clb2 
during early mitosis, despite rising levels of Clb2. This can be seen 
in Figure 6A, in which we plot steady-state levels of Cdc28/Clb2 
activity as a function of Clb2 levels. The red lines show plots in 
which the final level of Cdc28/Clb2 activity was normalized to 1 to 
emphasize the different shapes of the curves. The blue lines show 
plots that were not normalized, which indicate the different levels 
of Cdc28/Clb2 activity achieved under each condition. In the 
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absence of ultrasensitivity (nH = 1), the levels of Cdc28/Clb2 activ-
ity rise in a nearly linear manner. In contrast, an ultrasensitive re-
sponse of Swe1 to Cdc28/Clb2 produces an initial rapid rise in 
Cdc28/Clb2 activity that then begins to level off (nH = 2.5). Thus 
the ultrasensitivity may allow the system to rapidly establish and 
maintain a low level of Cdc28/Clb2 activity that can initiate early 
mitotic events, while preventing a further rise in Cdc28/Clb2 activ-
ity that would trigger full entry into mitosis.
We also carried out an analysis of the effects of varying 
PP2ACdc55 activity on the system. This showed that the level of 
active Cdc28/Clb2 is strongly influenced by levels of PP2ACdc55 
activity, which provided further evidence that PP2ACdc55 can tune 
the system to control the level of Cdc28/Clb2 activity (Figure 
6B). This implies that regulation of PP2ACdc55 could be an impor-
tant mechanism for controlling levels of active Cdc28/Clb2 dur-
ing early mitosis.
A quantitative model for systems-level regulation 
of Cdc28 and Swe1
We next generated a mechanistically detailed mathematical model 
to test whether signaling interactions known to occur during mitosis 
are capable of generating a system that exhibits the proposed 
threshold behavior. We based the model on 
the chemical reactions described schemati-
cally in Figure 6C. Details of the model are 
provided in the Supplemental Information.
A sample simulation of the model, which 
is set in motion by the introduction of 
steadily increasing levels of Clb2, is shown 
in Figure 6D. The system has several dozen 
variables; however, for simplicity, only three 
key variables are displayed in the simula-
tion: levels of Clb2, active Cdc28/Clb2, 
and active Swe1. Initially, Cdc28/Clb2 is ac-
tivated since active Swe1 is unavailable. 
After a delay in which the intermediate 
states of Swe1 are being formed, active 
Swe1 is produced, which then inactivates 
Cdc28/Clb2 through phosphorylation, 
leading to a decrease in Cdc28/Clb2 activ-
ity. At this time, a basal level of Cdc28/Clb2 
activity is reached and maintained. At 
steady state, the Cdc28/Clb2 dimer is un-
dergoing cycles of inhibition by Swe1 and 
activation by Mih1, which leads to a low 
basal level of Cdc28/Clb2 activity. Previous 
work has shown that a low basal activity of 
Mih1/Cdc25 is present during interphase 
and early mitosis, which would allow for the 
reversibility of Cdc28 inhibition (Kumagai 
and Dunphy, 1992; Harvey et al., 2005). In 
Xenopus, the low basal activity of Cdc25 is 
stimulated fivefold during entry into mito-
sis, which is thought to help trigger full ac-
tivation of Cdc28 (Kumagai and Dunphy, 
1992).
Importantly, the model shows that 
the opposing activity of PP2ACdc55 can act 
as a threshold to generate a dynamic 
steady state in which a low level of 
Cdc28/Clb2 activity is generated and 
maintained in early mitosis in the pres-
ence of Swe1, despite rising Clb2 levels.
DISCUSSION
Measurement of mitotic Cdk1 activity in vertebrate cells has shown 
that a low plateau level of Cdk1 activity is generated in early mitosis, 
which is followed by switch-like, full activation of Cdk1 later in mito-
sis (Pomerening et al., 2005; Lindqvist et al., 2007; Deibler and 
Kirschner, 2010). In budding yeast, low-level activation of Cdc28 in 
early mitosis initiates mitotic spindle assembly, as well as a feedback 
loop that promotes transcription of mitotic cyclins (Amon et al., 
1993; Rahal and Amon, 2008). Low-level activation of Cdk1 in early 
mitosis therefore appears to be a conserved mitotic control mecha-
nism. A mechanism that keeps Cdk1 activity low as cyclin levels rise 
would allow the cell to accumulate inactive Cdk1/cyclin complexes, 
which could be rapidly activated via posttranslational modifications 
to trigger full entry into mitosis. Low-level activation of Cdk1 in the 
presence of Wee1 would also allow the cell to become poised for 
cell division once checkpoint conditions have been satisfied. Here 
we define a systems-level mechanism by which a low level of Cdk1 
activity can be generated and maintained in early mitosis, despite 
the presence of the Wee1 inhibitor and constantly rising cyclin 
levels.
FIGURE 6: Systems-level regulation of Cdc28 and Swe1 by PP2ACdc55 in early mitosis. (A) The 
steady-state activity of Cdc28/Clb2 was calculated by intersecting the dose–response curves 
in Figure S7, A–B, and the resulting values were plotted for different Clb2 concentrations. The 
solid and dotted lines were determined using the solid and dotted lines in Figure S7A (see 
Supplemental Information for details, including parameter values; a.u., arbitrary units). The red 
lines show plots in which the final level of Cdc28/Clb2 activity was normalized to 1 to 
emphasize the different shapes of the curves. The blue lines show plots that were not 
normalized, which indicate the different levels of Cdc28/Clb2 activity achieved under each 
condition. (B) Using the response curve for nH = 2.5 in (A), the same graph as in (A) is plotted 
for increasing PP2ACdc55 concentrations. (C and D) A detailed quantitative model of the 
interactions among Swe1, Clb2, Cdc28, and PP2ACdc55 during entry into mitosis. (C) The 
chemical reactions that define the network, using mass-action terms for each interaction. 
(D) A sample time course of the model, set in motion by a steadily increasing Clb2 
concentration. The red line shows rising Clb2 levels, the green line shows Cdc28/Clb2 activity, 
and the blue line shows Swe1 activity.
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Cdc28-dependent regulation of Swe1 during early mitosis
Quantitative mass spectrometry revealed that Cdc28/Clb2 phos-
phorylates Swe1 on a set of minimal Cdc28 consensus sites. Analysis 
of a swe1-8A mutant that lacked consensus sites showed that they 
are required for Swe1 activity in vivo and for formation of a Swe1-
Cdc28/Clb2 complex that likely maintains Cdc28 in the inhibited 
state in vivo. Together, these observations suggest that phosphory-
lation of Cdc28 consensus sites alone drives stimulation of Swe1 
activity.
Standard mass spectrometry showed that Cdc28/Clb2 phospho-
rylated Swe1 on both nonconsensus sites and consensus sites. How-
ever, the nonconsensus sites were phosphorylated at stoichiome-
tries that were too low to be measured. Phosphorylation of these 
sites likely represents inefficient phosphorylation events that occur 
before Swe1 inhibits Cdc28/Clb2. The detection of these events 
emphasizes the high sensitivity of mass spectrometry, as well as the 
importance of using quantitative approaches to reveal which sites 
are phosphorylated at significant stoichiometries.
PP2ACdc55 restrains activation of Swe1 by Cdc28
Previous studies found that inactivation of budding yeast PP2ACdc55 
causes increased inhibitory phosphorylation of Cdc28 and delayed 
mitotic progression; however, the precise roles of PP2ACdc55 were 
unclear (Lin and Arndt, 1995; Minshull et al., 1996; Yang et al., 2000; 
Pal et al., 2008). We discovered that an important function of 
PP2ACdc55 in budding yeast is to oppose phosphorylation of Swe1 
by Cdc28/Clb2. Since initial phosphorylation of Swe1 by Cdc28/
Clb2 activates Swe1, we propose that PP2ACdc55 sets a threshold 
that limits activation of Swe1 during early mitosis, thereby allowing 
accumulation of a low level of active Cdc28/Clb2 that can initiate 
the positive feedback loop that promotes transcription of mitotic 
cyclins (Amon et al., 1993). Diverse in vivo experiments support this 
model. For example, inactivation of Cdc28 in vivo caused rapid de-
phosphorylation of Swe1 (Harvey et al., 2005). Conversely, inactiva-
tion of PP2ACdc55 caused premature phosphorylation of Swe1, and a 
mutant form of Swe1 that lacked Cdc28 consensus sites did not 
undergo premature phosphorylation when PP2ACdc55 was inacti-
vated. Overexpression of Cdc55 caused delayed phosphorylation 
of Swe1. Together, these observations demonstrate that PP2ACdc55 
opposes the initial activating phosphorylation of Swe1 that occurs 
on consensus sites. Mild overexpression of Swe1 was lethal in 
cdc55Δ cells, consistent with the idea that PP2ACdc55 opposes acti-
vation of Swe1. In addition, inactivation of Cdc55 caused a pro-
longed delay in accumulation of Clb2, which is consistent with a 
failure in the positive feedback loop that promotes transcription of 
CLB2. Deletion of SWE1 rescued the delay, which established that it 
was due to inappropriate inhibition of Cdc28/Clb2 by Swe1. Cells 
that lack PP2ACdc55 may eventually enter mitosis when enough Clb2 
accumulates via basal transcription to overcome the inhibitory activ-
ity of Swe1 without the help of PP2ACdc55.
In vitro reconstitution provided further support for the model. 
Cdc28/Clb2 was able to efficiently phosphorylate Swe1 under the 
conditions that prevail in early mitosis, when there are low levels of 
Cdc28/Clb2 and Swe1 is in excess. Moreover, purified PP2ACdc55 
could effectively oppose phosphorylation of Swe1 by Cdc28/Clb2. 
Swe1 phosphorylation in the reconstituted system approached 
steady state on a timescale that was relevant in vivo.
In addition to causing defects in early mitotic events, inactivation 
of the cdc55-4 allele caused a prolonged delay in spindle elonga-
tion. Thus PP2ACdc55 must also control events occurring later in mi-
tosis that are required for the normal timing of spindle elongation. 
The nature of the these PP2ACdc55-dependent events is unknown; 
however, the fact that swe1Δ almost completely eliminated the de-
lay in spindle elongation indicates that PP2ACdc55 exerts its effects 
on mitotic progression primarily via control of Cdc28 inhibitory 
phosphorylation. Since a high level of Cdc28 activity is required for 
spindle elongation, the delay may be due to delayed accumulation 
of active Cdc28 in the presence of hyperactive Swe1 (Rahal and 
Amon, 2008). Previous work found that inactivation of PP2ACdc55 
causes premature exit from a mitotic arrest. This phenotype is inde-
pendent of Cdc28 inhibitory phosphorylation, which indicates an 
additional role for PP2ACdc55 in late mitosis (Minshull et al., 1996; 
Queralt et al., 2006; Tang and Wang, 2006; Chiroli et al., 2007).
In previous work, we discovered that Mih1 is dephosphorylated 
during entry into mitosis by a form of PP2ACdc55 that is tightly associ-
ated with a pair of redundant regulatory subunits called Zds1 and 
Zds2 (Pal et al., 2008; Wicky et al., 2010). The Zds1/2 proteins are 
not required for dephosphorylation of Swe1, which suggests they 
specifically target PP2ACdc55 to Mih1. Although the functional sig-
nificance of Mih1 dephosphorylation is unclear, these results, when 
combined with the results reported here, indicate that PP2ACdc55 
regulates the phosphorylation states of both Swe1 and Mih1. Im-
portantly, cdc55Δ is lethal in mih1Δ cells and the lethality is rescued 
by swe1Δ (Pal et al., 2008). Since the effects of deleting CDC55 in 
mih1Δ cells cannot be due to misregulation of Mih1, this observa-
tion argues that PP2ACdc55 plays a direct role in inhibition of Swe1.
Systems-level control of Cdc28 activity during 
entry into mitosis
We used quantitative analysis and mathematical modeling to test 
the PP2ACdc55 threshold model and to investigate the systems-level 
mechanisms by which PP2ACdc55 controls Swe1 and Cdc28. These 
approaches revealed that the most phosphorylated form of Swe1 
was generated in an ultrasensitive manner in response to rising lev-
els of cdc28-Y19F/Clb2 in the reconstituted system. Systems-level 
modeling further suggested that the biological function of the 
ultrasensitivity in the system is to allow a relatively stable level of 
Cdc28/Clb2 activity to be rapidly generated and maintained in early 
mitosis despite rising Clb2 levels. The data from the reconstituted 
system could be fitted to a simple mathematical model, in which 
Cdc28/Clb2 and PP2ACdc55 act in the linear range to move Swe1 
through a series of isoforms in a phosphorylation “pipeline.” The 
linear pipeline model provides what is perhaps the simplest abstract 
description of the system that could account for the data and is in-
tended as a guide for future investigations into the underlying 
mechanisms, rather than as a definitive description of the system. 
Although the model demonstrated that ultrasensitivity could be ac-
counted for by multi-step effects caused by multi-site phosphoryla-
tion of Swe1, our results thus far do not rule out the possibility that 
cooperativity or other factors contribute to the observed ultrasensi-
tivity in multi-site Swe1 phosphorylation.
We also generated a mechanistically detailed systems-level 
model to test whether a system based on known signaling interac-
tions in mitosis can generate the behavior postulated by the thresh-
old model. This analysis provided an important proof-of-principle 
test of the PP2ACdc55 threshold model.
Quantitative analysis, modeling, and analysis of phosphoryla-
tion site mutants suggest that multi-site phosphorylation of Swe1 
by Cdc28/Clb2 may occur in an ordered and distributive manner. 
However, rigorous experimental verification of an ordered phos-
phorylation mechanism will require direct analysis of the phospho-
forms that are produced at specific times during reactions, which 
may be achievable in the future via mass spectrometry. Combined 
experimental and mathematical analysis is an iterative process. Our 
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analysis thus far provides a first iteration and suggests new experi-
mental tests that will lead to a more refined understanding of the 
system.
Numerous studies in vertebrate cells and yeast have detected 
stepwise activation of Cdk1 during entry into mitosis (Pomerening 
et al., 2005; Lindqvist et al., 2007; Rahal and Amon, 2008; Deibler 
and Kirschner, 2010). In contrast, a recent study utilizing an in vivo 
biosensor detected a steady rise in mitotic Cdk1 activity in verte-
brate cells (Gavet and Pines, 2010). The biosensor measured Cdk1 
activity via phosphorylation of a Cdk1 consensus site in an engi-
neered protein, which triggered a phosphorylation-dependent 
binding event that resulted in a fluorescence resonance energy 
transfer signal. Chemical inhibition of Cdk1 caused a slow loss of the 
biosensor signal over a period of 25 min, which indicated that the 
biosensor has low temporal resolution. It is unclear whether a phos-
phatase acts efficiently on the biosensor phosphosite, so the slow 
loss of the signal could be due to cyclin destruction. The low tempo-
ral resolution of the biosensor may preclude detection of dynamic 
Cdk1 regulation. For example, if Cdk1 phosphorylates the biosen-
sor and is then inhibited by Wee1, the low temporal resolution of 
the biosensor likely means the biosensor signal would persist long 
after Cdk1 is inhibited by Wee1. Thus the biosensor may not detect 
dynamic Wee1-dependent mechanisms that keep Cdk1 activity low 
in early mitosis.
In vertebrate cells, it has been proposed that Cdk1/cyclin A turns 
down Wee1 activity to allow low-level activation of Cdk1/cyclin B in 
early mitosis (Deibler and Kirschner, 2010). In budding yeast, the 
Clb3 cyclin appears before Clb2 during entry into mitosis, which 
suggests that it could turn down Swe1 activity. If this were true, one 
would predict that deletion of the CLB3 gene should cause a pheno-
type consistent with hyperactivity of Swe1. However, deletion of the 
CLB3 gene causes no obvious phenotype (Fitch et al., 1992). We 
therefore favor the PP2ACdc55 threshold model as a mechanism to 
restrain Swe1 activity in early mitosis. PP2A also plays a crucial role in 
controlling mitosis in vertebrate cells, so it could play a conserved 
role in restraining the activity of Wee1 family members. However, 
additional experiments will be necessary to test the cyclin A hypoth-
esis and the role of PP2A in controlling Wee1 activity in vertebrates.
Phosphorylation of Wee1 has also been analyzed in Xenopus ex-
tracts (Kim and Ferrell, 2007). Increasing amounts of Cdk1/cyclin B1 
were added to interphase egg extracts, which were incubated for 
1 h to allow the system to reach steady state. Phosphorylation of 
Wee1 was measured using a phosphospecific antibody that recog-
nized a single Cdk1 consensus site. These experiments measured a 
Hill coefficient of 3.5 for phosphorylation of the site in crude ex-
tracts. In contrast, the Hill coefficient for phosphorylation of the site 
by purified cdk1-AF/cyclin B1 showed a lower Hill coefficient of 1.5. 
Further work suggested a model in which high concentrations of 
Cdk1 substrates act as competitive inhibitors in vivo to restrain 
phosphorylation of Wee1 by Cdk1 and to generate ultrasensitivity. 
An important difference between Xenopus egg Wee1 and Swe1 is 
that phosphorylation of Cdk1 consensus sites on Wee1 is thought to 
inactivate Wee1, although it has not yet been possible to replace 
endogenous Xenopus egg Wee1 with a phosphorylation site mu-
tant to test this model (Kim et al., 2005). The difference could be 
due to the presence of unique phosphorylation sites on Swe1 that 
function to stimulate Swe1 activity. A similar module could be pres-
ent in human somatic Wee1, since it is also thought to undergo ini-
tial activation by Cdk1 (Deibler and Kirschner, 2010). Currently, it is 
difficult to compare regulation of Wee1 in yeast and Xenopus, due 
to their evolutionary divergence and the significant technical differ-
ences in how experimental analysis has been carried out.
Theoretical analysis has shown that opposing kinase and phos-
phatase activities could play an important role in generating di-
verse and powerful signaling behaviors (Goldbeter and Koshland, 
1981, 1982, 1984; Ferrell, 1996; Thomson and Gunawardena, 
2009). In a number of cases, experimental analysis has provided 
support for this idea (LaPorte and Koshland, 1983; Nakajima et al., 
2005). Often, however, phosphatases are thought of as playing 
relatively simple roles, such as serving to reverse the activated 
state of a signaling pathway once the original stimulus has been 
removed, or blocking phosphorylation of proteins to inhibit signal 
transduction. Analysis of the mechanisms that control Cdc28 ac-
tivity in early mitosis suggests that opposing kinase and phos-
phatase activities are capable of generating a dynamic systems-
level mechanism for modulation of signal strength. Similar 
mechanisms may be used to modulate signal strength in other 
signaling networks.
MATERIALS AND METHODS
Strains, plasmids, and culture conditions
The strains, plasmids, and culture conditions used for this study are 
listed in the Supplemental Information. For time-course experi-
ments, cells were grown in YPD or YPDA medium (1% yeast extract, 
2% peptone, 2% dextrose, with or without 0.004% adenine sulfate) 
overnight at room temperature prior to synchronization. For induced 
expression experiments, cells were grown overnight in YEP medium 
(1% yeast extract, 2% peptone, 0.004% adenine sulfate) containing 
2% glycerol/2% ethanol or 2% raffinose and then induced with 2% 
galactose.
Western blotting
For quantitative Western blotting, proteins were transferred to 
Immobilon-FL (Millipore, Billerica, MA) polyvinylidene fluoride 
membranes and probed with mouse monoclonal HA antibody fol-
lowed by Alexa Fluor 647 donkey anti–mouse secondary antibody. 
Blots were scanned using a Typhoon 9410 Variable Mode Imager 
(Amersham Biosciences, GE Healthcare, Waukesha, WI), and the 
results were quantified with Odyssey version 2.1.12 (LI-COR Bio-
sciences, Lincoln, NE) and MATLAB software (Mathworks, Natick, 
MA).
Protein purifications
Immunoaffinity purifications of Cdc28/Clb2-3×HA, cdc28-Y19F/
Clb2-3×HA, 3×HA-Swe1, 3×HA-swe1-8A, 3×HA-swe1-10ncs, 
PP2ACdc55-3×HA, and PP2ARts1-3×HA were carried out in the presence of 
1 M KCl as previously described, with some modifications (Harvey 
et al., 2005). Detailed methods for purification of proteins, including 
growth conditions for SILAC, are provided in the Supplemental 
Information.
SILAC analysis
Swe1 labeled with heavy isotope was made by expressing 
3×HA-Swe1 from the GAL1 promoter in lys1Δ cells in medium 
containing l-lysine-13C6,15N2 hydrochloride as the sole source of 
lysine. The protein was purified by immunoaffinity chromatogra-
phy and treated with λ phosphatase to create an unphosphory-
lated reference protein. The isotope-labeled 3×HA-Swe1 was 
mixed with unphosphorylated or phosphorylated 3×HA-Swe1, 
and the stoichiometry of phosphorylation was determined by 
monitoring the depletion of unphosphorylated protein. Stan-
dard site mapping was also carried out to identify all phospho-
rylated sites, including those not phosphorylated at significant 
stoichiometries.
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